Cytiva’s proprietary NxGen microfluidics technology, available with our NanoAssemblr Platform, enables LNP formation in a non-turbulent, exquisitely-controlled manner, resulting in consistent and reproducible results. The process maximizes drug loading, particle quality, and the scope of compositions possible with fully scalable results.
Contact us today to request a quote or learn more at www.cytiva.com
7 май 2024
